NEW ASSOCIATION BETWEEN 4-{3-[CIS-HEXAHYDROCYCLOPENTA[C]PYRROL-2 (1H) -YL]PROPOXY??BENZAMIDE AND AN ACETYLCHOLINESTERASE INHIBITOR, AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT

The present invention is a pharmaceutical, a derivative of 4-{3-[cis-hexahydrocyclopenta[c]pyrrol-2(1H)-yl]propoxy}benzamide of chemical formula (I) or an additional salt with a pharmaceutically active acid or base, and an acetylcholinesterase inhibitor. [Reference numerals] (AA) Test procedure; (BB...

Full description

Saved in:
Bibliographic Details
Main Authors TROCME THIBIERGE CARYN, SORS AURORE, KEIME GUIBERT FLORENCE
Format Patent
LanguageEnglish
Korean
Published 30.04.2014
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention is a pharmaceutical, a derivative of 4-{3-[cis-hexahydrocyclopenta[c]pyrrol-2(1H)-yl]propoxy}benzamide of chemical formula (I) or an additional salt with a pharmaceutically active acid or base, and an acetylcholinesterase inhibitor. [Reference numerals] (AA) Test procedure; (BB) Tronche et al. changed after 2010; (CC) Food; (DD) No food; (EE) Contextual; (FF) Serial distinguishment test; (GG) Two different contexts of two continuous distinguishment; (HH,SS) Treatment; (II,TT) Room C; (JJ,UU) Injection of a compound or glycone; (KK) Learn; (LL,OO,WW) Room A; (MM,PP) hole with a bait; (NN) Room B; (QQ) Retention time; (RR) Animal quarters; (VV) Test; (XX) Correct response; (YY) Mistake; (ZZ) Interference response
Bibliography:Application Number: KR20140037996